PCK1 Protects against Mitoribosomal Defects in Diabetic Nephropathy in Mouse Models

糖异生 内分泌学 磷酸烯醇丙酮酸羧激酶 内科学 糖尿病肾病 化学 糖酵解 肾病 糖尿病 生物 医学 生物化学 新陈代谢
作者
Kazuhiro Hara,Yusuke Sakamaki,Masanori Tamaki,Shu Wakino
出处
期刊:Journal of The American Society of Nephrology 卷期号:34 (8): 1343-1365 被引量:3
标识
DOI:10.1681/asn.0000000000000156
摘要

Significance Statement Renal gluconeogenesis plays an important role in the pathogenesis of diabetic nephropathy (DN). Proximal tubular phosphoenolpyruvate carboxykinase1 (PEPCK1) is the rate-limiting enzyme in gluconeogenesis. However, the functions of PEPCK1 have not been elucidated. We describe the novel role of PEPCK1 as a mitoribosomal protector using Pck1 transgenic (TG) mice and knockout mice. Pck1 blocks excessive glycolysis by suppressing the upregulation of excess HK2 (the rate-limiting enzyme of glycolysis). Notably, Pck1 overexpression retains mitoribosomal function and suppresses renal fibrosis. The renal and mitoribosomal protective roles of Pck1 may provide important clues for understanding DN pathogenesis and provide novel therapeutic targets. Background Phosphoenolpyruvate carboxykinase (PEPCK) is part of the gluconeogenesis pathway, which maintains fasting glucose levels and affects renal physiology. PEPCK consists of two isoforms—PEPCK1 and PEPCK2—that the Pck1 and Pck2 genes encode. Gluconeogenesis increases in diabetic nephropathy (DN), escalating fasting and postprandial glucose levels. Sodium–glucose cotransporter-2 inhibitors increase hepatic and renal gluconeogenesis. We used genetically modified mice to investigate whether renal gluconeogenesis and Pck1 activity are renoprotective in DN. Methods We investigated the expression of Pck1 in the proximal tubule (PTs) of streptozotocin (STZ)-treated diabetic mice. We studied the phenotypic changes in PT-specific transgenic (TG) mice and PT-specific Pck1 conditional knockout (CKO) mice. Results The expression of Pck1 in PTs was downregulated in STZ-treated diabetic mice when they exhibited albuminuria. TG mice overexpressing Pck1 had improved albuminuria, concomitant with the mitigation of PT cell apoptosis and deposition of peritubular type IV collagen. Moreover, CKO mice exhibited PT cell apoptosis and type IV collagen deposition, findings also observed in STZ-treated mice. Renal fibrotic changes in CKO mice were associated with increasing defects in mitochondrial ribosomes (mitoribosomes). The TG mice were protected against STZ-induced mitoribosomal defects. Conclusion PCK1 preserves mitoribosomal function and may play a novel protective role in DN.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
和谐的修洁完成签到 ,获得积分10
4秒前
王小白发布了新的文献求助10
5秒前
6秒前
7秒前
刘晨瑶完成签到,获得积分10
9秒前
直率钢笔发布了新的文献求助10
9秒前
丘山完成签到,获得积分10
9秒前
9秒前
酷炫邑完成签到,获得积分10
9秒前
香蕉觅云应助borden1采纳,获得10
10秒前
程雯慧发布了新的文献求助10
11秒前
皇家搓澡师完成签到,获得积分10
13秒前
乐乐应助jenny采纳,获得10
14秒前
16秒前
丘山发布了新的文献求助10
16秒前
Hello应助罗布林卡采纳,获得10
18秒前
李小伟完成签到,获得积分10
19秒前
赘婿应助不懈奋进采纳,获得10
20秒前
27秒前
我要发文章完成签到,获得积分10
27秒前
幽默皮皮虾完成签到,获得积分10
29秒前
独钓寒江雪完成签到 ,获得积分10
31秒前
31秒前
33秒前
勤恳易真完成签到,获得积分10
34秒前
乐乐应助酷酷亦凝采纳,获得10
34秒前
隐形曼青应助cqnuly采纳,获得10
38秒前
TCM_XZ完成签到 ,获得积分10
40秒前
可爱的函函应助不懈奋进采纳,获得10
43秒前
Owen应助Fashioner8351采纳,获得10
44秒前
44秒前
45秒前
sxr完成签到,获得积分10
46秒前
47秒前
48秒前
传奇3应助xiaofan采纳,获得10
49秒前
如故发布了新的文献求助10
51秒前
55秒前
情怀应助可靠的寒风采纳,获得10
56秒前
搁浅发布了新的文献求助10
57秒前
高分求助中
Teaching Social and Emotional Learning in Physical Education 900
Plesiosaur extinction cycles; events that mark the beginning, middle and end of the Cretaceous 800
Recherches Ethnographiques sue les Yao dans la Chine du Sud 500
Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism 500
Chinese-English Translation Lexicon Version 3.0 500
[Lambert-Eaton syndrome without calcium channel autoantibodies] 460
Wisdom, Gods and Literature Studies in Assyriology in Honour of W. G. Lambert 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2393901
求助须知:如何正确求助?哪些是违规求助? 2097800
关于积分的说明 5286084
捐赠科研通 1825319
什么是DOI,文献DOI怎么找? 910154
版权声明 559943
科研通“疑难数据库(出版商)”最低求助积分说明 486418